BioNxt Solutions Inc. (OTCMKTS:BNXTF) Sees Significant Decline in Short Interest

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 4,100 shares, a decrease of 10.9% from the January 15th total of 4,600 shares. Based on an average trading volume of 2,700 shares, the days-to-cover ratio is presently 1.5 days.

BioNxt Solutions Stock Up 4.3 %

Shares of BNXTF stock traded up $0.01 on Friday, reaching $0.33. The company had a trading volume of 9,561 shares, compared to its average volume of 3,001. The stock has a market capitalization of $37.86 million, a PE ratio of -8.35 and a beta of 0.69. BioNxt Solutions has a one year low of $0.11 and a one year high of $0.49. The business’s 50-day moving average is $0.27 and its 200 day moving average is $0.21.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its earnings results on Friday, November 29th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.